Cancer Biomarkers Market
Cancer Biomarkers Market - Global Industry Assessment & Forecast
#
Pages:
146
Base Year:
2022
May - 2022
Format:
Report Code:
VMR-1613
Segments Covered
By
Biomarkers Type Protein Biomarkers, Genetic Biomarkers, Others
-
By
Cancer Type Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Thyroid Cancer, Bladder Cancer, Non-Hodgkin's Lymphoma Kidney Cancer, Others
-
By
Profiling Technologies Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics
-
By
Application Research & Development, Prognostics, Risk Assessment, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 14.08 Billion |
 Revenue 2030:
|
USD 50.47 Billion |
 Revenue CAGR
(2023 - 2030): |
17.30% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cancer Biomarkers Market Segment Analysis
- Cancer Biomarkers Biomarkers Type Outlook (Revenue, USD Million, 2018 - 2030)
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Cancer Biomarkers Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Cancer Biomarkers Profiling Technologies Outlook (Revenue, USD Million, 2018 - 2030)
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Cancer Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
- Research & Development
- Prognostics
- Risk Assessment
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
-
North America Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
-
North America Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
-
North America Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- U.S.
- U.S. Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- U.S. Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- U.S. Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- U.S. Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- U.S. Cancer Biomarkers Market, by Biomarkers Type
- Canada
- Canada Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Canada Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Canada Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Canada Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Canada Cancer Biomarkers Market, by Biomarkers Type
-
Mexico
- Mexico Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Mexico Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Mexico Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Mexico Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Mexico Cancer Biomarkers Market, by Biomarkers Type
-
North America Cancer Biomarkers Market, by Biomarkers Type
- Europe
-
Europe Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
-
Europe Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
-
Europe Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
-
Europe Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- U. K.
- U.K. Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- U.K. Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- U.K. Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- U.K. Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- U.K. Cancer Biomarkers Market, by Biomarkers Type
- France
- France Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- France Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- France Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- France Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- France Cancer Biomarkers Market, by Biomarkers Type
-
Germany
- Germany Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Germany Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Germany Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Germany Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Germany Cancer Biomarkers Market, by Biomarkers Type
-
Italy
- Italy Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Italy Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Italy Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Italy Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Italy Cancer Biomarkers Market, by Biomarkers Type
-
Spain
- Spain Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Spain Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Spain Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Spain Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Spain Cancer Biomarkers Market, by Biomarkers Type
-
Rest of Europe
- Rest of Europe Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Rest of Europe Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Rest of Europe Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Rest of Europe Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Rest of Europe Cancer Biomarkers Market, by Biomarkers Type
-
Europe Cancer Biomarkers Market, by Biomarkers Type
- Asia Pacific
-
Asia Pacific Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
-
Asia Pacific Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
-
Asia Pacific Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
-
Asia Pacific Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- China
- China Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- China Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- China Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- China Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- China Cancer Biomarkers Market, by Biomarkers Type
- Japan
- Japan Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Japan Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Japan Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Japan Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Japan Cancer Biomarkers Market, by Biomarkers Type
-
Germany
- Germany Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Germany Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Germany Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Germany Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Germany Cancer Biomarkers Market, by Biomarkers Type
-
India
- India Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- India Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- India Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- India Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- India Cancer Biomarkers Market, by Biomarkers Type
-
South Korea
- South Korea Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- South Korea Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- South Korea Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- South Korea Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- South Korea Cancer Biomarkers Market, by Biomarkers Type
-
South East Asia
- South East Asia Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- South East Asia Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- South East Asia Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- South East Asia Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- South East Asia Cancer Biomarkers Market, by Biomarkers Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Rest of Asia Pacific Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Rest of Asia Pacific Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Rest of Asia Pacific Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Rest of Asia Pacific Cancer Biomarkers Market, by Biomarkers Type
-
Asia Pacific Cancer Biomarkers Market, by Biomarkers Type
- Latin America
-
Latin America Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
-
Latin America Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
-
Latin America Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
-
Latin America Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Brazil
- Brazil Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Brazil Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Brazil Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Brazil Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Brazil Cancer Biomarkers Market, by Biomarkers Type
- Argentina
- Argentina Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Argentina Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Argentina Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Argentina Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Argentina Cancer Biomarkers Market, by Biomarkers Type
-
Rest of Latin America
- Rest of Latin America Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Rest of Latin America Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Rest of Latin America Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Rest of Latin America Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Rest of Latin America Cancer Biomarkers Market, by Biomarkers Type
-
Latin America Cancer Biomarkers Market, by Biomarkers Type
- Middle East & Africa
-
Middle East & Africa Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
-
Middle East & Africa Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
-
Middle East & Africa Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
-
Middle East & Africa Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- GCC Countries
- GCC Countries Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- GCC Countries Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- GCC Countries Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- GCC Countries Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- GCC Countries Cancer Biomarkers Market, by Biomarkers Type
- South Africa
- South Africa Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- South Africa Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- South Africa Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- South Africa Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- South Africa Cancer Biomarkers Market, by Biomarkers Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cancer Biomarkers Market, by Biomarkers Type
- Protein Biomarkers
- Genetic Biomarkers
- Others
- Rest of Middle East & Africa Cancer Biomarkers Market, by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Leukemia
- Thyroid Cancer
- Bladder Cancer
- Non-Hodgkin's Lymphoma Kidney Cancer
- Others
- Rest of Middle East & Africa Cancer Biomarkers Market, by Profiling Technologies
- Omics Technologies
- Imaging Technologies
- Immunoassay
- Bioinformatics
- Cytogenetics
- Rest of Middle East & Africa Cancer Biomarkers Market, by Application
- Research & Development
- Prognostics
- Risk Assessment
- Others
- Rest of Middle East & Africa Cancer Biomarkers Market, by Biomarkers Type
-
Middle East & Africa Cancer Biomarkers Market, by Biomarkers Type
- North America
Vantage Market
Research | 28-May-2022
FAQ
Frequently Asked Question
What is the global demand for Cancer Biomarkers in terms of revenue?
-
The global Cancer Biomarkers valued at USD 14.08 Billion in 2022 and is expected to reach USD 50.47 Billion in 2030 growing at a CAGR of 17.30%.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), Qiagen N.V. (Netherlands), Illumina Inc. (US), Bio-Rad Laboratories Inc. (US), Abbott Laboratories (US), Bio Mérieux SA (US), Becton-Dickinson and Company (US), Merck Millipore (US), Agilent Technologies (US), Myriad Genetics Inc. (US), Sysmex Corporation (Japan), Hologic Inc. (US), Quest Diagnostics (US), Centogene N.V. (Germany), PerkinElmer Inc. (US), Siemens Healthineers (Germany), Exact Sciences (US), R&D Systems Inc. (US), BioVision Inc. (US), Olink (Sweden), Asuragen Inc. (US), Meso Scale Diagnostics LLC (US), Invivoscribe Inc. (US), Seegene Technologies Inc. (South Korea).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 17.30% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cancer Biomarkers include
- Rising technological advancements in the development of cancer biomarkers
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cancer Biomarkers in 2022.
